Trial Profile
Evaluating Impact of Azithromycin Mass Drug Administrations on All-cause Mortality and Antibiotic Resistance: Morbidity Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Otitis media; Pelvic inflammatory disorders; Sexually transmitted infections
- Focus Therapeutic Use
- Acronyms MORDOR2
- 11 Jan 2021 Status changed from recruiting to completed.
- 08 Nov 2019 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
- 08 Nov 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2020.